Costs and clinical outcomes among patients with second-line non-small cell lung cancer in the outpatient community setting. [electronic resource]
Producer: 20120504Description: 212-8 p. digitalISSN:- 1556-1380
- Adult
- Aged
- Aged, 80 and over
- Ambulatory Care
- Antineoplastic Agents -- economics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Clinical Laboratory Techniques
- Disease-Free Survival
- Docetaxel
- Erlotinib Hydrochloride
- Female
- Glutamates -- economics
- Guanine -- analogs & derivatives
- Health Services -- statistics & numerical data
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Office Visits
- Pemetrexed
- Proportional Hazards Models
- Protein Kinase Inhibitors -- economics
- Quinazolines -- economics
- Taxoids -- economics
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.